Document jmjJ6Y9z68O22aBq0Zk1kL17Z

11/8/03 draft XOM to host next SHS Annual Meeting in Fairfax, VA L. Twerdok to calculate savings for reducing remaining annual meeting from 3 to 2 B. Doll to contact M. Bird concerning reprogramming of QA/QC funds Technical Budget Committee to contact SHS principals for detailed budget re- analysis cost explanations for review to identify cost efficiencies B. Doll to arrange for Yimei Zhou of EMBSI to work full time on exposure assessment IH management in Shanghai L. Twerdok inform Madeleine that API will not be organizing 2005 annual meeting API inform all SHS participants of change in venue for 2005 annual meeting once ExxonMobil provides API with details Budget Action Plan Action Estimated Lead Amount ($K) Contact BP 1700 XOM & CVT APCO 250 L. Russo Legal 50 P. Clegg & G. Kyle Reduce annual meeting 3 ~ 2 65 OC Committee over next 3 years & hold in US QA/QC 100 Technical Cmtte. Contingency 100 API revise budget Statisticians & database manager 100 Technical Cmtte Case accrual schedule ? Technical Cmtte acceleration Generate list of anticipated ? Technical Cmtte publications ME case accrual ends when 200 ? Technical Cmtte high exposure cases recruited (-1200 cases) EMBSI recruit full time exposure (800?) B. Doll expert (Yimei Zhou) Total $2450K Due Date (to API) 12/10/04 " " " " " " " " " " " " Joint Clinical & Molecular Laboratory (JCML) Sustainability Discussions: Sustainability expert Andrew Roberts (CoP) gave a brief overview of how to develop sustainability plans & projects, emphasizing that o the sponsors need a clear idea of the goals of the sustainability effort (function to be maintained, benefits of maintaining effort, funding requirements, etc), o a business plan needs to be developed by appropriate participants, and o communication strategies need to be developed for likely scenarios for the outcome of the sustainability plan. The OC identified several potential future uses/users of the JCML o Shanghai hospitals for clinical diagnostic work o Researchers for diagnostic and molecular capabilities (e.g. NCI), and further investigations with banked tissue samples SH ELL-MCCLU RG-056995 11/8/03 draft o Pharmaceutical/Biotech company use o "Safe Blood", which is an organization dedicated to ensure safe blood collection for transfusions. The organization will be expanding its program into China in the near future. Once Fudan makes decision for JCML to be managed by Fudan University or Fudan School of Public Health, BHRC (or 3rd party designee) should contact newly appointed JCML Director to facilitate development of laboratory business plan. ACTIONS Items: o Technical Committee to discuss with R. Irons if it would be useful for sponsor in-country representatives to meet with Fudan to emphasize importance of maintaining laboratory o L. Russo to contact APCO China for advice if/how BHRC can influence laboratory disposition decision by Fudan. Get advice by 12/04, for OC discussion in 1/05. o M. Johnston to draft strawman of transition plan goals for January OC meeting o OC to provide M. Johnston with in-house sustainable development contacts o OC to consider whether to involve NCI in JCML transition/sustainability, if NCI interested in following up as indicated at the 10/04 Int'I Benzene Symposium. o OC to meet in Houston (CoP) January 31 & February 1,2005 Technical Committee Update: P. Beatty presented an update on the October International Benzene Symposium o Meeting was data rich with interesting new data o SHS presentations were wellreceived. O. Wong presented the design of the case control study and R. Irons presented an overview of all studies and development of the laboratory. R. Irons then went on to review data from a subset of highly exposed workers. o NCI has expressed an interest in collaborating with AHS on future case control study in Shanghai As indicated in August, exposure information in Shanghai is less robust than originally indicated in the feasibility study. The case-control study will have a semiquantitative, rather than a full quantitative exposure assessment. Detailed exposure assessment update will be presented at next meeting. Next OC Meetings: Date: Thursday, December 16, 2004 Time: 8:30 A - 5:00 P Location: API offices, Washington, DC Agenda items to include: o Budget revision o Outreach o Exposure update o Financial monitoring/audits o Site visit to JCML in Shanghai, since 2005 Annual Meeting will be in Fairfax, VA (Select OC & TC members, Jerry Rice, Paul Lombardo) o BHRC committee roles & responsibilities SH ELL-MCCLU RG-056996 11/8/03 draft o 2004 action item update o 2004 plan o preliminary 2005 plan Date: Monday, January 31 and Tuesday, February 1,2005 Time: 1 - 5 P on Monday; 8 A - noon on Tuesday Location: Houston (hosted by CoP) Agenda items to include: o JCML transition Objective of transition plan Transition plan goals Potential laboratory sustainability outcomes, once SHS is complete SH ELL-MCCLU RG-056997